NCT00483756 - Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients | Biotech Hunter

Enrollment

338

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions

Kidney Transplantation

Interventions

DRUG

Cyclosporine

Standard of care

DRUG

CP-690,550

CP-690,550 15 mg BID for Months 1-6, then 10 mg BID for Months 7-12

DRUG

CP-690,550

CP-690,550 15 mg BID for Months 1-3, then 10 mg BID for Months 4-12

Trial Locations (69)

1070

Pfizer Investigational Site, Anderlecht

2050

Pfizer Investigational Site, Camperdown

2145

Pfizer Investigational Site, Westmead

3000

Pfizer Investigational Site, Leuven

3050

Pfizer Investigational Site, Parkville

3168

Pfizer Investigational Site, Clayton

5000

Pfizer Investigational Site, Adelaide

5011

Pfizer Investigational Site, Woodville

10029

Pfizer Investigational Site, New York

10117

Pfizer Investigational Site, Berlin

10595

Pfizer Investigational Site, Valhalla

19102

Pfizer Investigational Site, Philadelphia

20246

Pfizer Investigational Site, Hamburg

21201

Pfizer Investigational Site, Baltimore

27514

Pfizer Investigational Site, Chapel Hill

29425

Pfizer Investigational Site, Charleston

31059

Pfizer Investigational Site, Toulouse

32610

Pfizer Investigational Site, Gainesville

Pfizer Investigational Site, Gainsville

33606

Pfizer Investigational Site, Tampa

40138

Pfizer Investigational Site, Bologna

44093

Pfizer Investigational Site, Nantes

48109

Pfizer Investigational Site, Ann Arbor

48202

Pfizer Investigational Site, Detroit

54500

Pfizer Investigational Site, Vandœuvre-lès-Nancy

55905

Pfizer Investigational Site, Rochester

60611

Pfizer Investigational Site, Chicago

60637

Pfizer Investigational Site, Chicago

63110

Pfizer Investigational Site, St Louis

72205

Pfizer Investigational Site, Little Rock

75204

Pfizer Investigational Site, Dallas

75246

Pfizer Investigational Site, Dallas

75743

Pfizer Investigational Site, Paris

76104

Pfizer Investigational Site, Fort Worth

80045

Pfizer Investigational Site, Aurora

90048

Pfizer Investigational Site, Los Angeles

90095

Pfizer Investigational Site, Los Angeles

92123

Pfizer Investigational Site, San Diego

94115

Pfizer Investigational Site, San Francisco

94143

Pfizer Investigational Site, San Francisco

94304

Pfizer Investigational Site, Palo Alto

94305

Pfizer Investigational Site, Stanford

97239

Pfizer Investigational Site, Portland

06504

Pfizer Investigational Site, New Haven

06510

Pfizer Investigational Site, New Haven

02215

Pfizer Investigational Site, Boston

01107

Pfizer Investigational Site, Springfield

01199

Pfizer Investigational Site, Springfield

07039

Pfizer Investigational Site, Livingston

27599-7155

Pfizer Investigational Site, Chapel Hill

27599-7211

Pfizer Investigational Site, Chapel Hill

27599-7360

Pfizer Investigational Site, Chapel Hill

90020-090

Pfizer Investigational Site, Porto Alegre

04038-002

Pfizer Investigational Site, São Paulo

04039-050

Pfizer Investigational Site, São Paulo

T6G 2B7

Pfizer Investigational Site, Edmonton

140 21

Pfizer Investigational Site, Prague

00168

Pfizer Investigational Site, Roma

3015 GD

Pfizer Investigational Site, Rotterdam

0027

Pfizer Investigational Site, Oslo

02-006

Pfizer Investigational Site, Warsaw

50-417

Pfizer Investigational Site, Wroclaw

3000-075

Pfizer Investigational Site, Coimbra

1069-166

Pfizer Investigational Site, Lisbon

110-744

Pfizer Investigational Site, Seoul

120-752

Pfizer Investigational Site, Seoul

138-736

Pfizer Investigational Site, Seoul

08036

Pfizer Investigational Site, Barcelona

08907

Pfizer Investigational Site, L'Hospitalet de Llobregat